Today: 8 February 2026
Subscribe
Browse Category

NYSE:TDW News 16 December 2025 - 9 January 2026

Tidewater Inc. (NYSE: TDW) Stock Drops on Dec. 16, 2025: What Happened, What Wall Street Forecasts, and What to Watch Next

Tidewater Inc. (NYSE: TDW) Stock Drops on Dec. 16, 2025: What Happened, What Wall Street Forecasts, and What to Watch Next

Tidewater Inc. (NYSE: TDW) had a rough session on Tuesday, December 16, 2025, with shares sliding sharply and closing well off the prior day’s levels—an attention-grabbing move for a company that sits at the crossroads of offshore energy activity, vessel day rates, and investor expectations for 2026. Below is a full, up-to-date wrap of today’s news, the latest forecasts and price targets, and the key fundamental and market drivers shaping sentiment around Tidewater stock right now. What happened to Tidewater stock today (Dec. 16, 2025)? TDW finished the day lower, with trading data showing a decisive downside move: Intraday coverage
16 December 2025
·

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop